1.Research progress on the correlation between stress hyperglycemia ratio and prognosis of acute ischemic stroke
Chinese Journal of Geriatrics 2025;44(5):671-675
Stress hyperglycemia is more common in patients with acute ischemic stroke and increases the risk of hemorrhagic transformation, neurological deterioration, poor functional recovery, stroke recurrence, and even death in patients with acute ischemic stroke, however, the response to stress hyperglycemia may be inconsistent among different treatment modalities.The Stress hyperglycemia ratio is used to identify and quantify this stressful state, in this article, we will review the correlation of stress hyperglycemia on the prognosis of patients with acute ischemic stroke after receiving different treatments, aiming to provide a theoretical basis for better predicting clinical prognosis and clinical treatment.
2.Influence evaluation of pharmaceutical quality control on medication therapy management services by the ECHO model
Kun LIU ; Huanhuan JIANG ; Yushuang LI ; Yan HUANG ; Qianying ZHANG ; Dong CHEN ; Xiulin GU ; Jinhui FENG ; Zijian WANG ; Yunfei CHEN ; Yajuan QI ; Yanlei GE ; Aishuang FU
China Pharmacy 2025;36(9):1123-1128
OBJECTIVE To evaluate the influence of pharmaceutical quality control on the efficiency and outcomes of standardized medication therapy management (MTM) services for patients with coronary heart disease by using Economic, Clinical and Humanistic Outcomes (ECHO) model. METHODS This study collected case data of coronary heart disease patients who received MTM services during January-March 2023 (pre-quality control implementation group, n=96) and June-August 2023 (post-quality control implementation group, n=164). Using propensity score matching analysis, 80 patients were selected from each group. The study subsequently compared the economic, clinical, and humanistic outcome indicators of pharmaceutical services between the two matched groups. RESULTS There were no statistically significant differences in baseline data between the two groups after matching (P>0.05). Compared with pre-quality control implementation group, the daily treatment cost (16.26 yuan vs. 24.40 yuan, P<0.001), cost-effectiveness ratio [23.12 yuan/quality-adjusted life year (QALY) vs. 32.32 yuan/QALY, P<0.001], and the incidence of general adverse drug reactions (2.50% vs. 10.00%, P=0.049) of post-quality control implementation group were decreased significantly; the utility value of the EuroQol Five-Dimensional Questionnaire (0.74± 0.06 vs. 0.71±0.07, P=0.003), the reduction in the number of medication related problems (1.0 vs. 0.5, P<0.001), the medication adherence score ([ 6.32±0.48) points vs. (6.10±0.37) points, P=0.001], and the satisfaction score ([ 92.56±1.52) points vs. (91.95±1.56) points, P=0.013] all showed significant improvements. Neither group experienced serious adverse drug reactions. There was no statistically significant difference in the incidence of new adverse reactions between the two groups (1.25% vs. 3.75%, P=0.310). CONCLUSIONS Pharmaceutical quality control can improve the quality of pharmaceutical care, and the ECHO model can quantitatively evaluate the effect of MTM services, making pharmaceutical care better priced and more adaptable to social needs, thus being worthy of promotion.
3.Research progress on the correlation between stress hyperglycemia ratio and prognosis of acute ischemic stroke
Chinese Journal of Geriatrics 2025;44(5):671-675
Stress hyperglycemia is more common in patients with acute ischemic stroke and increases the risk of hemorrhagic transformation, neurological deterioration, poor functional recovery, stroke recurrence, and even death in patients with acute ischemic stroke, however, the response to stress hyperglycemia may be inconsistent among different treatment modalities.The Stress hyperglycemia ratio is used to identify and quantify this stressful state, in this article, we will review the correlation of stress hyperglycemia on the prognosis of patients with acute ischemic stroke after receiving different treatments, aiming to provide a theoretical basis for better predicting clinical prognosis and clinical treatment.
4.Collection of autologous peripheral hematopoietic stem cells in patients with sequential double transplantation of solid tumors and effect analysis
Ying ZHANG ; Yushuang LIU ; Qianxia ZHUANG ; Nanhai WU ; Zhouyang LIU ; Hongyan LIU ; Qi LIU ; Zikuan GUO ; Yuan SUN
Chinese Journal of Blood Transfusion 2022;35(3):269-271
【Objective】 To explore the methods and safety of autologous peripheral hematopoietic stem cells collection in patients with sequential double transplantation of solid tumors and conduct efficacy analysis. 【Methods】 Peripheral blood stem cells were collected from 27 patients with solid tumors after routine mobilization of rhG-CSF and rhGM-CSF.A specific program was made for the patients.The condition and cooperation degree of children were comprehensively evaluated before cell collection, and a femoral venous catheterization was inserted to ensure the cells collected smoothly.A mononuclear cell collection(MNC) program was selected, and machine parameters were set based on the patient's low body weight.The number of mononuclear cell (MNC) and the CD34+ cell was detected by flow cytometry for retrospective analysis. 【Results】 A total of 73 cell collections were performed in 27 patients, and the number of mononuclear cells and CD34+ cells was 12.586(10.22~19.586)×108/kg and 13.575(7.275~23.825)×106/kg, respectively, which can meet the requirement of sequential double transplantation. No intoxication of citrate and other serious adverse reactions occurred, and the follow-up was generally in good condition. 【Conclusion】 The method is effective and safe for pediatric patients, even for pediatric patients with low weight. Sufficient stem cells can be collected for patients with solid tumors by this method to meet the requirement of sequential double transplantation.

Result Analysis
Print
Save
E-mail